Hypocretin-Neurogenesis Coupling Therapy

Target: HCRT Composite Score: 0.452 Price: $0.46▼2.0% Citation Quality: Pending neurodegeneration Status: debated
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
🟡 ALS / Motor Neuron Disease 🔴 Alzheimer's Disease 🔥 Neuroinflammation 🟢 Parkinson's Disease 🧠 Neurodegeneration
✓ All Quality Gates Passed
Quality Report Card click to collapse
C
Composite: 0.452
Top 61% of 531 hypotheses
T3 Provisional
Single-source or model-inferred
Needs composite score ≥0.60 (current: 0.45) for Supported
D Mech. Plausibility 15% 0.35 Top 94%
D Evidence Strength 15% 0.30 Top 90%
A Novelty 12% 0.85 Top 32%
D Feasibility 12% 0.25 Top 92%
C Impact 12% 0.40 Top 93%
B Druggability 10% 0.60 Top 52%
D Safety Profile 8% 0.30 Top 89%
A Competition 6% 0.80 Top 33%
C+ Data Availability 5% 0.50 Top 72%
D Reproducibility 5% 0.25 Top 98%
Evidence
15 supporting | 10 opposing
Citation quality: 100%
Debates
2 sessions B
Avg quality: 0.69
Convergence
0.38 D 30 related hypothesis share this target

From Analysis:

Sleep disruption as cause and consequence of neurodegeneration

Sleep disruption as cause and consequence of neurodegeneration

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Adenosine-Astrocyte Metabolic Reset
Score: 0.557 | Target: ADORA2A
Circadian Clock-Autophagy Synchronization
Score: 0.547 | Target: CLOCK
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.546 | Target: MTNR1A
Noradrenergic-Tau Propagation Blockade
Score: 0.510 | Target: ADRA2A
Sleep Spindle-Synaptic Plasticity Enhancement
Score: 0.491 | Target: CACNA1G
Orexin-Microglia Modulation Therapy
Score: 0.488 | Target: HCRTR2

→ View full analysis & all 7 hypotheses

Description

Molecular Mechanism and Rationale

The hypocretin-neurogenesis coupling therapy targets the intricate molecular network connecting the hypocretin (orexin) system to adult hippocampal neurogenesis through multiple converging pathways. Hypocretin-1 (HCRT-1) and hypocretin-2 (HCRT-2), derived from the HCRT gene, are neuropeptides produced exclusively by approximately 10,000-20,000 neurons in the lateral hypothalamus. These peptides bind to two G-protein coupled receptors: hypocretin receptor 1 (HCRTR1) and hypocretin receptor 2 (HCRTR2), which are differentially distributed throughout the brain with particularly high expression in the hippocampal dentate gyrus.

...

Figures & Visualizations

Pathway diagram for CLOCK
Pathway diagram for CLOCK pathway diagram
Debate overview for sda-2026-04-01-gap-v2-18cf98ca
Debate overview for sda-2026-04-01-gap-v2-18cf98ca debate overview
Pathway diagram for ADRA2A
Pathway diagram for ADRA2A pathway diagram
Evidence heatmap for CLOCK (2 hypotheses)
Evidence heatmap for CLOCK (2 hypotheses) evidence heatmap
Score comparison (7 hypotheses)
Score comparison (7 hypotheses) score comparison
Pathway diagram for ADORA2A
Pathway diagram for ADORA2A pathway diagram

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

graph TD
    A["HCRT gene<br/>expression"]
    B["Hypocretin-1 and<br/>Hypocretin-2<br/>peptides"]
    C["HCRTR1 receptor<br/>binding"]
    D["HCRTR2 receptor<br/>binding"]
    E["Gq/11 protein<br/>activation"]
    F["Gs protein<br/>activation"]
    G["PLC activation<br/>and IP3/DAG<br/>production"]
    H["cAMP elevation<br/>and PKA<br/>activation"]
    I["Calcium release<br/>and PKC<br/>activation"]
    J["CREB<br/>phosphorylation"]
    K["BDNF and<br/>neurotrophin<br/>expression"]
    L["Adult hippocampal<br/>neurogenesis"]
    M["Cognitive function<br/>improvement"]
    N["Neurodegeneration<br/>progression"]

    A -->|"peptide synthesis"| B
    B -->|"receptor binding"| C
    B -->|"receptor binding"| D
    C -->|"signal transduction"| E
    D -->|"signal transduction"| F
    E -->|"downstream signaling"| G
    F -->|"downstream signaling"| H
    G -->|"second messengers"| I
    H -->|"convergent pathway"| J
    I -->|"convergent pathway"| J
    J -->|"transcriptional activation"| K
    K -->|"promotes"| L
    L -->|"enhances"| M
    L -->|"counteracts"| N

    classDef normal fill:#4fc3f7,stroke:#333,stroke-width:2px
    classDef therapeutic fill:#81c784,stroke:#333,stroke-width:2px
    classDef pathology fill:#ef5350,stroke:#333,stroke-width:2px
    classDef outcome fill:#ffd54f,stroke:#333,stroke-width:2px
    classDef genetic fill:#ce93d8,stroke:#333,stroke-width:2px

    class A genetic
    class B,C,D,E,F,G,H,I normal
    class J,K,L therapeutic
    class M,N outcome

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for O43612

View AlphaFold Structure

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.35 (15%) Evidence 0.30 (15%) Novelty 0.85 (12%) Feasibility 0.25 (12%) Impact 0.40 (12%) Druggability 0.60 (10%) Safety 0.30 (8%) Competition 0.80 (6%) Data Avail. 0.50 (5%) Reproducible 0.25 (5%) 0.452 composite
25 citations 25 with PMID 25 medium Validation: 100% 15 supporting / 10 opposing
Evidence Matrix — sortable by strength/year, click Abstract to expand
ClaimTypeSourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Hypocretin-1 directly stimulates neural stem cell …SupportingCell Stem Cell MEDIUM20170.00PMID:28159567
Hypocretin neurons are progressively lost in Alzhe…SupportingBrain MEDIUM20140.00PMID:24733677
Intranasal hypocretin-1 administration improves co…SupportingJournal of Neur… MEDIUM20070.00PMID:17636114
HCRTR2 agonist danavorexton (TAK-925) successfully…SupportingNature Medicine MEDIUM20210.00PMID:33539543
Adult hippocampal neurogenesis persists throughout…SupportingNature Medicine MEDIUM20190.00PMID:30760929
CSF hypocretin-1 levels positively correlate with …SupportingJAMA Neurology MEDIUM2019-PMID:31058787-
Exercise synergistically enhances hypocretin-media…SupportingNature Neurosci… MEDIUM20150.00PMID:25559265
Hypocretin promotes newborn neuron survival and sy…SupportingCell MEDIUM20170.00PMID:29235455
Sleep disruption accelerates amyloid-beta accumula…SupportingScience MEDIUM20130.33PMID:24136970
Pattern separation deficits in early Alzheimer…SupportingNature Communic… MEDIUM20170.00PMID:28213546
Inactivation of hypocretin receptor-2 signaling in…SupportingMol Psychiatry MEDIUM20240.00PMID:38123729
Hypocretin/orexin in arousal and stress.SupportingBrain Res MEDIUM20100.00PMID:19748490
Mechanism for Hypocretin-mediated sleep-to-wake tr…SupportingProc Natl Acad … MEDIUM20120.00PMID:22955882
The neuronal circuit between nociceptin/orphanin F…SupportingVitam Horm MEDIUM20150.00PMID:25677777
A Role for Hypocretin/Orexin in Metabolic and Slee…SupportingCell Metab MEDIUM20180.00PMID:29805100
Adult hippocampal neurogenesis in humans drops to …OpposingNature MEDIUM20180.00PMID:29513649
Hypocretin/orexin primarily promotes wakefulness; …OpposingNature Reviews … MEDIUM20190.00PMID:30543234
Newborn neurons generated in amyloid-rich environm…OpposingAlzheimer'… MEDIUM20200.00PMID:31685530
Dual orexin receptor agonists cause dose-limiting …OpposingNature Medicine MEDIUM20210.00PMID:33539543
Chronic hypocretin receptor activation leads to re…OpposingJournal of Neur… MEDIUM2016-PMID:27568067-
Neurogenesis enhancement without concurrent neurop…OpposingCell Stem Cell MEDIUM20180.00PMID:29777924
Sleep-wake dysregulation in AD involves multiple n…OpposingNature Reviews … MEDIUM20190.00PMID:31197153
Hippocampal neurogenesis may not significantly con…OpposingCell MEDIUM2018-PMID:30573821-
Challenges in the development of therapeutics for …OpposingProg Neurobiol MEDIUM20170.00PMID:26721620
Sleep deprivation and cerebrospinal fluid biomarke…OpposingSleep MEDIUM20180.00PMID:29425372
Legacy Card View — expandable citation cards

Supporting Evidence 15

Hypocretin-1 directly stimulates neural stem cell proliferation through HCRTR1-mediated PI3K/Akt/mTOR signalin… MEDIUM
Hypocretin-1 directly stimulates neural stem cell proliferation through HCRTR1-mediated PI3K/Akt/mTOR signaling in adult dentate gyrus
Cell Stem Cell · 2017 · PMID:28159567 · Q:0.00
ABSTRACT

In this paper we report the steady-state optical properties of a series of site-directed mutants in the Fenna-Matthews-Olson (FMO) complex of Chlorobaculum tepidum, a photosynthetic green sulfur bacterium. The FMO antenna complex has historically been used as a model system for energy transfer due to the water-soluble nature of the protein, its stability at room temperature, as well as the availability of high-resolution structural data. Eight FMO mutants were constructed with changes in the environment of each of the bacteriochlorophyll a pigments found within each monomer of the homotrimeric FMO complex. Our results reveal multiple changes in low temperature absorption, as well as room temperature CD in each mutant compared to the wild-type FMO complex. These datasets were subsequently used to model the site energies of each pigment in the FMO complex by employing three different Hamiltonians from the literature. This enabled a basic approximation of the site energy shifts imparted o

Hypocretin neurons are progressively lost in Alzheimer's disease, with 25-40% reduction occurring before clini… MEDIUM
Hypocretin neurons are progressively lost in Alzheimer's disease, with 25-40% reduction occurring before clinical dementia onset
Brain · 2014 · PMID:24733677 · Q:0.00
ABSTRACT

IMPORTANCE: IgG4-related hypertrophic pachymeningitis (IgG4-RHP) is an increasingly recognized manifestation of IgG4-related disease, a fibroinflammatory condition that can affect virtually any organ. It is estimated that IgG4-RHP may account for a high proportion of cases of hypertrophic pachymeningitis once considered idiopathic. OBJECTIVE: To summarize the current knowledge on IgG4-RHP including its pathological, clinical, and radiological presentations. Particular emphasis is placed on diagnostic and therapeutic implications. EVIDENCE REVIEW: This review is based on 21 reports published in the English medical literature since 2009. PubMed was searched with the following terms: IgG4, pachymeningitis, IgG4-related pachymeningitis, IgG4-related disease, IgG4-related, and IgG4 meningitis. Only cases with biopsy-proven IgG4-RHP were considered and included in this review. FINDINGS: Little is known with certainty regarding the pathogenesis of IgG4-RHP. The presence of oligoclonally restr

Intranasal hypocretin-1 administration improves cognitive performance and enhances slow-wave sleep in human su… MEDIUM
Intranasal hypocretin-1 administration improves cognitive performance and enhances slow-wave sleep in human subjects
Journal of Neuroscience · 2007 · PMID:17636114 · Q:0.00
ABSTRACT

Single nucleotide polymorphisms (SNPs) in two genes regulating insulin secretion, SLC2A2 (encoding GLUT2) and ABCC8 (encoding SUR1), were associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in the Finnish Diabetes Prevention Study (DPS). We determined whether physical activity (PA), assessed annually with a questionnaire, modified the association of SNPs in SLC2A2 and ABCC8 with the conversion to T2D in the combined intervention and control groups of the DPS. Finnish overweight subjects with IGT (N = 479) were followed for an average of 4.1 yr. The interaction of the SNPs with the change in PA on the conversion to T2D was assessed using Cox regression with adjustments for the other components of the intervention (dietary changes, weight reduction). The carriers of the common homozygous genotype of rs5393, rs5394, or rs5404 of SLC2A2 and rs3758947 of ABCC8 who were in the lower third of the change in moderate-to-vigorous PA during the follow-up

HCRTR2 agonist danavorexton (TAK-925) successfully restores wakefulness in narcolepsy patients, validating pha… MEDIUM
HCRTR2 agonist danavorexton (TAK-925) successfully restores wakefulness in narcolepsy patients, validating pharmacological hypocretin replacement therapy
Nature Medicine · 2021 · PMID:33539543 · Q:0.00
ABSTRACT

BACKGROUND: In vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatments conventionally consist of a fresh embryo transfer, possibly followed by one or more cryopreserved embryo transfers in subsequent cycles. An alternative option is to freeze all suitable embryos and transfer cryopreserved embryos in subsequent cycles only, which is known as the 'freeze all' strategy. This is the first update of the Cochrane Review on this comparison. OBJECTIVES: To evaluate the effectiveness and safety of the freeze all strategy compared to the conventional IVF/ICSI strategy in women undergoing assisted reproductive technology. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, and two registers of ongoing trials from inception until 23 September 2020 for relevant studies, checked references of publications found, and contacted study authors to obtain additional data. SELECTION CRITERIA: Two revi

Adult hippocampal neurogenesis persists throughout human lifespan and is significantly reduced in Alzheimer's … MEDIUM
Adult hippocampal neurogenesis persists throughout human lifespan and is significantly reduced in Alzheimer's disease patients
Nature Medicine · 2019 · PMID:30760929 · Q:0.00
ABSTRACT

Microglia have critical roles not only in neural development and homeostasis, but also in neurodegenerative and neuroinflammatory diseases of the central nervous system1-4. These highly diverse and specialized functions may be executed by subsets of microglia that already exist in situ, or by specific subsets of microglia that develop from a homogeneous pool of cells on demand. However, little is known about the presence of spatially and temporally restricted subclasses of microglia in the central nervous system during development or disease. Here we combine massively parallel single-cell analysis, single-molecule fluorescence in situ hybridization, advanced immunohistochemistry and computational modelling to comprehensively characterize subclasses of microglia in multiple regions of the central nervous system during development and disease. Single-cell analysis of tissues of the central nervous system during homeostasis in mice revealed specific time- and region-dependent subtypes of

CSF hypocretin-1 levels positively correlate with hippocampal volume and episodic memory performance in AD pat… MEDIUM
CSF hypocretin-1 levels positively correlate with hippocampal volume and episodic memory performance in AD patients
JAMA Neurology · 2019 · PMID:31058787
Exercise synergistically enhances hypocretin-mediated neurogenesis through activation of AMPK and BDNF signali… MEDIUM
Exercise synergistically enhances hypocretin-mediated neurogenesis through activation of AMPK and BDNF signaling pathways
Nature Neuroscience · 2015 · PMID:25559265 · Q:0.00
ABSTRACT

Anderson disease (ANDD) or chylomicron retention disease (CMRD) is a rare, hereditary lipid malabsorption syndrome associated with mutations in the SAR1B gene that is characterized by failure to thrive and hypocholesterolemia. Although the SAR1B structure has been resolved and its role in formation of coat protein II (COPII)-coated carriers is well established, little is known about the requirement for SAR1B during embryogenesis. To address this question, we have developed a zebrafish model of Sar1b deficiency based on antisense oligonucleotide knockdown. We show that zebrafish sar1b is highly conserved among vertebrates; broadly expressed during development; and enriched in the digestive tract organs, brain, and craniofacial skeleton. Consistent with ANDD symptoms of chylomicron retention, we found that dietary lipids in Sar1b-deficient embryos accumulate in enterocytes. Transgenic expression analysis revealed that Sar1b is required for growth of exocrine pancreas and liver. Furthermo

Hypocretin promotes newborn neuron survival and synaptic integration through ERK1/2-mediated BDNF upregulation MEDIUM
Cell · 2017 · PMID:29235455 · Q:0.00
ABSTRACT

We report a high spatial resolution mass spectrometry (MS) system that allows us to image live hippocampal tissue slices under open-air atmospheric pressure (AP) and ambient temperature conditions at the subcellular level. The method is based on an efficient desorption process by femtosecond (fs) laser assisted with nanoparticles and a subsequent ionization step by applying nonthermal plasma, termed AP nanoparticle and plasma assisted laser desorption ionization (AP-nanoPALDI) MS method. Combining the AP-nanoPALDI with microscopic sample scanning, MS imaging with spatial resolution of 2.9 µm was obtained. The observed AP-nanoPALDI MS imaging clearly revealed the differences of molecular composition between the apical and basal dendrite regions of a hippocampal tissue. In addition, the AP-nanoPALDI MS imaging showed the decrease of cholesterol in hippocampus by treating with methyl β-cyclodextrin, which exemplifies the potential of AP-nanoPALDI for live tissue imaging for various biomed

Sleep disruption accelerates amyloid-beta accumulation by impairing glymphatic clearance during slow-wave slee… MEDIUM
Sleep disruption accelerates amyloid-beta accumulation by impairing glymphatic clearance during slow-wave sleep phases
Science · 2013 · PMID:24136970 · Q:0.33
ABSTRACT

The conservation of sleep across all animal species suggests that sleep serves a vital function. We here report that sleep has a critical function in ensuring metabolic homeostasis. Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep. Thus, the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.

Pattern separation deficits in early Alzheimer's disease correlate with reduced adult hippocampal neurogenesis… MEDIUM
Pattern separation deficits in early Alzheimer's disease correlate with reduced adult hippocampal neurogenesis markers
Nature Communications · 2017 · PMID:28213546 · Q:0.00
ABSTRACT

Sewage samples have been investigated to study the norovirus concentrations in sewage or the genotypes of noroviruses circulating in human populations. However, the statistical relationship between the concentration of the virus and the number of infected individuals and the clinical importance of genotypes or strains detected in sewage are unclear. In this study, we carried out both environmental and clinical surveillance of noroviruses for 3 years, 2013 to 2016. We performed cross-correlation analysis of the concentrations of norovirus GI or GII in sewage samples collected weekly and the reported number of gastroenteritis cases. Norovirus genotypes in sewage were also analyzed by pyrosequencing and compared with those identified in stool samples. The cross-correlation analysis found the peak coefficient (R = 0.51) at a lag of zero, indicating that the variation in the GII concentration, expressed as the log10 number of copies per milliliter, was coincident with that in the gastroente

Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cogn… MEDIUM
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control.
Mol Psychiatry · 2024 · PMID:38123729 · Q:0.00
ABSTRACT

Hypocretin/Orexin (HCRT/OX) and dopamine (DA) are both key effectors of salience processing, reward and stress-related behaviors and motivational states, yet their respective roles and interactions are poorly delineated. We inactivated HCRT-to-DA connectivity by genetic disruption of Hypocretin receptor-1 (Hcrtr1), Hypocretin receptor-2 (Hcrtr2), or both receptors (Hcrtr1&2) in DA neurons and analyzed the consequences on vigilance states, brain oscillations and cognitive performance in freely behaving mice. Unexpectedly, loss of Hcrtr2, but not Hcrtr1 or Hcrtr1&2, induced a dramatic increase in theta (7-11 Hz) electroencephalographic (EEG) activity in both wakefulness and rapid-eye-movement sleep (REMS). DAHcrtr2-deficient mice spent more time in an active (or theta activity-enriched) substate of wakefulness, and exhibited prolonged REMS. Additionally, both wake and REMS displayed enhanced theta-gamma phase-amplitude coupling. The baseline waking EEG of DAHcrtr2-deficient mice exhibite

Hypocretin/orexin in arousal and stress. MEDIUM
Brain Res · 2010 · PMID:19748490 · Q:0.00
ABSTRACT

Multiple lines of evidence indicate that hypocretin/orexin (HCRT) participates in the regulation of arousal and arousal-related process. For example, HCRT axons and receptors are found within a variety of arousal-related systems. Moreover, when administered centrally, HCRT exerts robust wake-promoting actions. Finally, a dysregulation of HCRT neurotransmission is associated with the sleep/arousal disorder, narcolepsy. Combined, these observations suggested that HCRT might be a key transmitter system in the regulation of waking. Nonetheless, subsequent evidence indicates that HCRT may not play a prominent role in the initiation of normal waking. Instead HCRT may participate in a variety of processes such as consolidation of waking and/or coupling metabolic state with behavioral state. Additionally, substantial evidence suggests a potential involvement of HCRT in high-arousal conditions, including stress. Thus, HCRT neurotransmission is closely linked to high-arousal conditions, includin

Mechanism for Hypocretin-mediated sleep-to-wake transitions. MEDIUM
Proc Natl Acad Sci U S A · 2012 · PMID:22955882 · Q:0.00
ABSTRACT

Current models of sleep/wake regulation posit that Hypocretin (Hcrt)-expressing neurons in the lateral hypothalamus promote and stabilize wakefulness by projecting to subcortical arousal centers. However, the critical downstream effectors of Hcrt neurons are unknown. Here we use optogenetic, pharmacological, and computational tools to investigate the functional connectivity between Hcrt neurons and downstream noradrenergic neurons in the locus coeruleus (LC) during nonrapid eye movement (NREM) sleep. We found that photoinhibiting LC neurons during Hcrt stimulation blocked Hcrt-mediated sleep-to-wake transitions. In contrast, when LC neurons were optically stimulated to increase membrane excitability, concomitant photostimulation of Hcrt neurons significantly increased the probability of sleep-to-wake transitions compared with Hcrt stimulation alone. We also built a conductance-based computational model of Hcrt-LC circuitry that recapitulates our behavioral results using LC neurons as t

The neuronal circuit between nociceptin/orphanin FQ and hypocretins/orexins coordinately modulates stress-indu… MEDIUM
The neuronal circuit between nociceptin/orphanin FQ and hypocretins/orexins coordinately modulates stress-induced analgesia and anxiety-related behavior.
Vitam Horm · 2015 · PMID:25677777 · Q:0.00
ABSTRACT

The neuropeptide nociceptin/orphanin FQ (N/OFQ), acting on its receptors (NOP), modulates a variety of biological functions and neurobehavior including nociception, stress responses, water and food-intake, locomotor activity, and spatial attention. N/OFQ is conventionally regarded as an "antiopiate" peptide in the brain because central administration of N/OFQ attenuates stress-induced analgesia (SIA) and produces anxiolytic effects. However, naloxone-irreversible SIA and anxiolytic action are unlikely to be mediated by the opiate system. Both N/OFQ and NOP receptors are expressed most abundantly in the hypothalamus, where two other neuropeptides, the hypocretins/orexins (Hcrts), are exclusively synthesized in the lateral hypothalamic area. N/OFQ and Hcrt regulate most cellular physiological responses in opposite directions (e.g., ion channel modulation and second messenger coupling), and produce differential modulations for almost all neurobehavior assessed, including sleep/wake, locom

A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Ca… MEDIUM
A Role for Hypocretin/Orexin in Metabolic and Sleep Abnormalities in a Mouse Model of Non-metastatic Breast Cancer.
Cell Metab · 2018 · PMID:29805100 · Q:0.00
ABSTRACT

We investigated relationships among immune, metabolic, and sleep abnormalities in mice with non-metastatic mammary cancer. Tumor-bearing mice displayed interleukin-6 (IL-6)-mediated peripheral inflammation, coincident with altered hepatic glucose processing and sleep. Tumor-bearing mice were hyperphagic, had reduced serum leptin concentrations, and enhanced sensitivity to exogenous ghrelin. We tested whether these phenotypes were driven by inflammation using neutralizing monoclonal antibodies against IL-6; despite the reduction in IL-6 signaling, metabolic and sleep abnormalities persisted. We next investigated neural populations coupling metabolism and sleep, and observed altered activity within lateral-hypothalamic hypocretin/orexin (HO) neurons. We used a dual HO-receptor antagonist to test whether increased HO signaling was causing metabolic abnormalities. This approach rescued metabolic abnormalities and enhanced sleep quality in tumor-bearing mice. Peripheral sympathetic denervat

Opposing Evidence 10

Adult hippocampal neurogenesis in humans drops to undetectable levels after adolescence, questioning the thera… MEDIUM
Adult hippocampal neurogenesis in humans drops to undetectable levels after adolescence, questioning the therapeutic relevance
Nature · 2018 · PMID:29513649 · Q:0.00
ABSTRACT

New neurons continue to be generated in the subgranular zone of the dentate gyrus of the adult mammalian hippocampus. This process has been linked to learning and memory, stress and exercise, and is thought to be altered in neurological disease. In humans, some studies have suggested that hundreds of new neurons are added to the adult dentate gyrus every day, whereas other studies find many fewer putative new neurons. Despite these discrepancies, it is generally believed that the adult human hippocampus continues to generate new neurons. Here we show that a defined population of progenitor cells does not coalesce in the subgranular zone during human fetal or postnatal development. We also find that the number of proliferating progenitors and young neurons in the dentate gyrus declines sharply during the first year of life and only a few isolated young neurons are observed by 7 and 13 years of age. In adult patients with epilepsy and healthy adults (18-77 years; n = 17 post-mortem sampl

Hypocretin/orexin primarily promotes wakefulness; therapeutic restoration could paradoxically worsen sleep fra… MEDIUM
Hypocretin/orexin primarily promotes wakefulness; therapeutic restoration could paradoxically worsen sleep fragmentation in dementia
Nature Reviews Neuroscience · 2019 · PMID:30543234 · Q:0.00
ABSTRACT

Despite the widespread use of nanotechnology in radio-imaging applications, lipoprotein based delivery systems have received only limited attention so far. These studies involve the synthesis of a novel hydrophobic radio-imaging tracer consisting of a hydrazinonicotinic acid (HYNIC)-N-dodecylamide and 99mTc conjugate that can be encapsulated into rHDL nanoparticles (NPs). These rHDL NPs can selectively target the Scavenger Receptor type B1 (SR-B1) that is overexpressed on most cancer cells due to excess demand for cholesterol for membrane biogenesis and thus can target tumors in vivo. We provide details of the tracer synthesis, characterization of the rHDL/tracer complex, in vitro uptake, stability studies and in vivo application of this new radio-imaging approach.

Newborn neurons generated in amyloid-rich environment show impaired survival and integration, limiting therape… MEDIUM
Newborn neurons generated in amyloid-rich environment show impaired survival and integration, limiting therapeutic potential
Alzheimer's & Dementia · 2020 · PMID:31685530 · Q:0.00
ABSTRACT

OBJECTIVE: To examine the reciprocal longitudinal associations between depression or anxiety with work-related injury (WRI) at a large employer in the southwestern United States. METHOD: Three administrative datasets (2011-2013) were merged: employee eligibility, medical and prescription claims, and workers' compensation claims. The sample contained 69 066 active employees. Depression and anxiety were defined as episodes of medical visits care (ie, claims) with corresponding ICD-9-CM codes. For an individual's consecutive claims, a new case of depression or anxiety was defined if more than 8 weeks have passed since the prior episode. The presence of a workers' compensation injury claim was used to identify WRI. Three-wave (health plan years 2011 or T1, 2012 or T2, and 2013 or T3) autoregressive cross-lagged models were used to estimate whether depression or anxiety predicted WRI, also if WRI predicted depression or anxiety in the following year(s). RESULTS: Depression predicted injury

Dual orexin receptor agonists cause dose-limiting side effects including cataplexy-like episodes and significa… MEDIUM
Dual orexin receptor agonists cause dose-limiting side effects including cataplexy-like episodes and significant appetite changes
Nature Medicine · 2021 · PMID:33539543 · Q:0.00
ABSTRACT

BACKGROUND: In vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatments conventionally consist of a fresh embryo transfer, possibly followed by one or more cryopreserved embryo transfers in subsequent cycles. An alternative option is to freeze all suitable embryos and transfer cryopreserved embryos in subsequent cycles only, which is known as the 'freeze all' strategy. This is the first update of the Cochrane Review on this comparison. OBJECTIVES: To evaluate the effectiveness and safety of the freeze all strategy compared to the conventional IVF/ICSI strategy in women undergoing assisted reproductive technology. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, and two registers of ongoing trials from inception until 23 September 2020 for relevant studies, checked references of publications found, and contacted study authors to obtain additional data. SELECTION CRITERIA: Two revi

Chronic hypocretin receptor activation leads to receptor desensitization and tolerance, potentially limiting l… MEDIUM
Chronic hypocretin receptor activation leads to receptor desensitization and tolerance, potentially limiting long-term efficacy
Journal of Neuroscience · 2016 · PMID:27568067
Neurogenesis enhancement without concurrent neuroprotection may create vulnerable young neurons susceptible to… MEDIUM
Neurogenesis enhancement without concurrent neuroprotection may create vulnerable young neurons susceptible to AD pathology
Cell Stem Cell · 2018 · PMID:29777924 · Q:0.00
ABSTRACT

OBJECTIVES: To explore inpatients experiences and views with regard to antibiotics in five European hospitals. METHODS: Qualitative study where a patient-centred framework was used to explore inpatients' experiences concerning antibiotic treatment. A purposeful sample of inpatients treated with antibiotics in five hospitals participated in interviews (all centres) and focus groups (Switzerland only). RESULTS: A total of 31 interviews (five in Belgium, ten in Croatia, nine in France, five in the Netherlands and two in Switzerland) and three focus groups (in Switzerland, 11 participants) were performed. The median age of participants was 61 years (range 33-86 years). The following main themes emerged: (a) patients trust doctors to take the best decisions for them even though communication concerning different antibiotic-related aspects is often insufficient, (b) patients feel that doctors do not prioritize communication due to time constraints and do not seem to adapt information based o

Sleep-wake dysregulation in AD involves multiple neurotransmitter systems beyond hypocretin, limiting single-t… MEDIUM
Sleep-wake dysregulation in AD involves multiple neurotransmitter systems beyond hypocretin, limiting single-target approaches
Nature Reviews Drug Discovery · 2019 · PMID:31197153 · Q:0.00
ABSTRACT

The global epidemic of prediabetes and diabetes has led to a corresponding epidemic of complications of these disorders. The most prevalent complication is neuropathy, of which distal symmetric polyneuropathy (for the purpose of this Primer, referred to as diabetic neuropathy) is very common. Diabetic neuropathy is a loss of sensory function beginning distally in the lower extremities that is also characterized by pain and substantial morbidity. Over time, at least 50% of individuals with diabetes develop diabetic neuropathy. Glucose control effectively halts the progression of diabetic neuropathy in patients with type 1 diabetes mellitus, but the effects are more modest in those with type 2 diabetes mellitus. These findings have led to new efforts to understand the aetiology of diabetic neuropathy, along with new 2017 recommendations on approaches to prevent and treat this disorder that are specific for each type of diabetes. In parallel, new guidelines for the treatment of painful di

Hippocampal neurogenesis may not significantly contribute to memory formation in aged brains due to limited in… MEDIUM
Hippocampal neurogenesis may not significantly contribute to memory formation in aged brains due to limited integration capacity
Cell · 2018 · PMID:30573821
Challenges in the development of therapeutics for narcolepsy. MEDIUM
Prog Neurobiol · 2017 · PMID:26721620 · Q:0.00
ABSTRACT

Narcolepsy is a neurological disorder that afflicts 1 in 2000 individuals and is characterized by excessive daytime sleepiness and cataplexy-a sudden loss of muscle tone triggered by positive emotions. Features of narcolepsy include dysregulation of arousal state boundaries as well as autonomic and metabolic disturbances. Disruption of neurotransmission through the hypocretin/orexin (Hcrt) system, usually by degeneration of the HCRT-producing neurons in the posterior hypothalamus, results in narcolepsy. The cause of Hcrt neurodegeneration is unknown but thought to be related to autoimmune processes. Current treatments for narcolepsy are symptomatic, including wake-promoting therapeutics that increase presynaptic dopamine release and anticataplectic agents that activate monoaminergic neurotransmission. Sodium oxybate is the only medication approved by the US Food and Drug Administration that alleviates both sleep/wake disturbances and cataplexy. Development of therapeutics for narcoleps

Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease. MEDIUM
Sleep · 2018 · PMID:29425372 · Q:0.00
ABSTRACT

STUDY OBJECTIVES: To investigate the cumulative effect of five consecutive nights of partial sleep deprivation (PSD) on a panel of cerebrospinal fluid (CSF) biomarkers in healthy adults. METHODS: A randomized, cross-over study conducted at the University of Gothenburg. The participants (N = 13) were healthy adults (20-40 years of age) with a normal sleeping pattern. The participants underwent a baseline sleep period consisting of five nights with 8 hr spent in bed. A subsequent period with PSD consisted of five nights of maximum 4 hr of sleep per night. Four participants were also subjected to a prolonged period of PSD consisting of eight nights with 4 hr of sleep per night. Sleep was monitored by means of observation, actigraphy, and continuous polysomnographic recordings. CSF samples were collected by routine lumbar puncture after each period. CSF biomarkers included the 38, 40, and 42 amino acid-long Aβ isoforms, total-τ, phospho-τ, orexin, monoamine metabolites (3-methoxy-4-hydroxy

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Novel Therapeutic Hypotheses: Sleep-Neurodegeneration Interface

1. Circadian Glymphatic Rescue Therapy

Description: Pharmacological enhancement of aquaporin-4 polarization and melatonin signaling could restore sleep-dependent glymphatic clearance of protein aggregates. This approach would target the circadian regulation of cerebrospinal fluid flow to prevent accumulation of amyloid-β and tau proteins during critical sleep phases.

Target: AQP4 (Aquaporin-4) and MTNR1A/1B (Melatonin receptors)

Supporting Evidence: Glymphatic system activity increases dramatically during sleep

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Sleep-Neurodegeneration Therapeutic Hypotheses

1. Circadian Glymphatic Rescue Therapy

Major Weaknesses:

  • Translation barrier: Most glymphatic evidence comes from rodent models with uncertain human relevance (PMID:30962395)
  • AQP4 targeting specificity: No established methods for selective CNS AQP4 enhancement without systemic effects
  • Oversimplified mechanism: Assumes AQP4 polarization is solely rate-limiting for clearance
Counter-Evidence:
  • Human glymphatic function shows minimal circadian variation compared to rodents (PMID:30962395)
  • AQ

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Practical Feasibility Assessment: Sleep-Neurodegeneration Therapeutics

1. Circadian Glymphatic Rescue Therapy

Revised Confidence: 0.45

Druggability Assessment

AQP4: Extremely challenging. No selective small molecule modulators exist. Protein is a water channel with limited allosteric sites. MTNR1A/1B: Highly druggable GPCRs with established pharmacology.

Chemical Matter & Existing Compounds

  • Melatonin receptor agonists: Ramelteon (Rozerem®), Tasimelteon (Hetlioz®), Agomelatine (Valdoxan®)
  • AQP4 modulators: None clinically viable. TGN-020 (research tool, po

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.250.500.75 created: post_process (2026-04-02 01:54)evidence: market_dynamics_seed (2026-04-02 18:16)score_update: post_process (2026-04-02T03:05)score_update: post_process (2026-04-02T04:17)score_update: post_process (2026-04-02T05:28)debate: debate_engine (2026-04-02T06:39)evidence: evidence_update (2026-04-02T07:50)evidence: evidence_update (2026-04-02T09:02)evidence: evidence_update (2026-04-02T10:13)debate: debate_engine (2026-04-02T11:24)evidence: evidence_update (2026-04-02T12:35)score_update: market_dynamics (2026-04-02T13:46)evidence: market_dynamics (2026-04-02T17:18)debate: debate_engine (2026-04-02T17:18)evidence: evidence_batch_update (2026-04-04T09:08)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.00 2026-04-022026-04-122026-04-15 Market PriceScoreevidencedebate 160 events
7d Trend
Stable
7d Momentum
▼ 0.3%
Volatility
Low
0.0146
Events (7d)
87
⚡ Price Movement Log Recent 15 events
Event Price Change Source Time
📄 New Evidence $0.471 ▲ 1.0% evidence_batch_update 2026-04-13 02:18
📄 New Evidence $0.466 ▲ 3.2% evidence_batch_update 2026-04-13 02:18
Recalibrated $0.452 ▼ 0.4% 2026-04-12 10:15
Recalibrated $0.453 ▼ 2.1% 2026-04-12 05:13
Recalibrated $0.463 ▼ 1.2% 2026-04-10 15:58
Recalibrated $0.469 ▲ 1.4% 2026-04-10 15:53
Recalibrated $0.462 ▲ 1.0% 2026-04-08 18:39
Recalibrated $0.457 ▲ 5.9% 2026-04-06 04:04
Recalibrated $0.432 ▼ 2.7% 2026-04-04 16:38
Recalibrated $0.444 ▲ 1.2% 2026-04-04 16:02
📄 New Evidence $0.438 ▲ 1.7% evidence_batch_update 2026-04-04 09:08
Recalibrated $0.431 ▼ 6.9% 2026-04-03 23:46
Recalibrated $0.463 ▲ 8.9% 2026-04-02 21:55
Recalibrated $0.425 ▼ 11.9% market_recalibrate 2026-04-02 19:14
💬 Debate Round $0.482 ▲ 0.7% debate_engine 2026-04-02 17:18

Clinical Trials (14) Relevance: 67%

0
Active
0
Completed
890
Total Enrolled
PHASE1
Highest Phase
Multidimensional Evaluation of Patients' Affected by Obstructive Apnea Syndrome (OSAS) Before and After Ventilotherapy N/A
RECRUITING · NCT06312956 · Istituto Auxologico Italiano
65 enrolled · 2024-02-29 · → 2026-06
This observational study aims to evaluate multiple dimensions of health in patients with Obstructive Sleep Apnea Syndrome (OSAS), before and after three weeks of ventilotherapy. Specifically, the stu
Obstructive Sleep Apnea Sleep Disorder Well-Being, Psychological
Continuous Positive Airway Pressure Ventilotherapy
Orexin and Tau Pathology in Cognitively Normal Elderly NA
COMPLETED · NCT03053908 · NYU Langone Health
25 enrolled · 2018-03-27 · → 2019-05-13
Alzheimer's disease (AD) is a common neurodegenerative disease characterized by the accumulation of amyloid plaques and neurofibrillary tangles. Current consensus is that the AD pathological process b
Elderly Alzheimer Disease
Actigraphy Nocturnal Polysomnograpahy (NPSG)
A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia. PHASE2
RECRUITING · NCT06823752 · Woolcock Institute of Medical Research
20 enrolled · 2025-05-13 · → 2026-04
The goal of this clinical trial is to explore the potential neuroprotective benefits of a dual orexin receptor antagonist (DORA) in adults with insomnia. The main questions it aims to answer are: * D
Insomnia
Lemborexant 10 MG Placebo
Multicenter Study on the Role of Neurodegeneration Biomarkers in Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime Sleepiness. N/A
UNKNOWN · NCT05795270 · Istituto Auxologico Italiano
100 enrolled · 2020-12-15 · → 2023-08-24
Excessive daytime sleepiness which still remains after an effective treatment with nocturnal ventilotherapy or with other specific treatments (positional therapy, oro-mandibular devices) in patients w
Sleep Apnea Syndromes
Treatment
Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy. PHASE3
COMPLETED · NCT01638403 · Bioprojet
180 enrolled · 2010-11 · → 2012-04
3\. RATIONALE FOR BF2.649 IN NARCOLEPSY Narcolepsy is a disabling syndrome affecting the generation and organizations of sleep and wakefulness, first described by Westphal and Gelineau in 19th century
Treatment of Excessive Daytime Sleepiness in Narcolepsy
BF2.649 Vigil palcebo
Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant PHASE2
UNKNOWN · NCT03755310 · Diego García-Borreguero, MD, PhD
43 enrolled · 2019-02 · → 2020-03
Suvorexant improves sleep latency and wake after sleep onset in patients with primary insomnia, and is FDA approved for this condition. However, no data exist on its effects in RLS, so far. The inves
Restless Legs Syndrome
Suvorexant Placebo
Evaluation of the Effectiveness of a Physical Activity Program on the Severity of Narcolepsy N/A
COMPLETED · NCT05460052 · Hospices Civils de Lyon
30 enrolled · 2022-08-26 · → 2023-11-24
Narcolepsy Type 1 (NT1) is a rare chronic neurological disorder resulting from the selective loss of hypocretin neurons. Patients with NT1 suffer from excessive daytime sleepiness, disrupted nighttime
Narcolepsy Type 1
Physical activity training program Weekly phone call. Personalized training plan.
Development and Application of Comprehensive Intervention Techniques for Adolescent Depression NA
UNKNOWN · NCT05945342 · First Affiliated Hospital of Zhejiang University
100 enrolled · 2023-01-31 · → 2024-12-31
In order to realize the early identification, risk warning and comprehensive intervention of adolescent depression, this project carried out research on the diagnosis platform of adolescent depression
Depressive Disorder Adolescent
Escitalopram Interpersonal Psychotherapy for Adolescent Escitalopram combined with psychotherapy
Comparison of Different Acceleration Modes of Transcranial Magnetic Stimulation NA
NOT_YET_RECRUITING · NCT06881030 · First Affiliated Hospital of Zhejiang University
45 enrolled · 2025-03-25 · → 2025-08-31
To compare the efficacy and safety of 6 times a day, 10 times a day acceleration mode and sham stimulation intervention for TRD, and to explore the antidepressant mechanism of accelerated mode, so as
Treatment Resistant Depression (TRD)
Noninvasive transcranial magnetic stimulation was administered six times daily Noninvasive transcranial magnetic stimulation was administered 10 times daily Sham
RAPA-501 Therapy for ALS PHASE2
RECRUITING · NCT04220190 · Rapa Therapeutics LLC
41 enrolled · 2025-01-02 · → 2026-07-01
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Amyotrophic Lateral Sclerosis
RAPA-501 Autologous T stem cells
MAD Phase I Study to Investigate Contraloid Acetate PHASE1
COMPLETED · NCT03955380 · Prof. Dr. Dieter Willbold
24 enrolled · 2018-12-12 · → 2019-04-03
This is a single-center multiple-ascending-dose clinical trial assessing the safety and tolerability of oral dosing of Contraloid acetate in healthy volunteers. The study drug Contraloid (alias RD2, a
Alzheimer Dementia Alzheimer Disease
Contraloid
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury N/A
UNKNOWN · NCT04820881 · Washington D.C. Veterans Affairs Medical Center
60 enrolled · 2021-10-01 · → 2024-09
This grant award entitled, "Cerebrovascular Reactivity and Oxygen Metabolism as Markers for Neurodegeneration after Traumatic Brain Injury" (hereafter, "Neurovascular Study"), aims to determine if neu
Neurodegenerative Diseases
Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease PHASE1
NOT_YET_RECRUITING · NCT07212088 · iCamuno Biotherapeutics Ltd.
12 enrolled · 2026-02-28 · → 2027-12-15
Parkinson's disease is a progressive neurodegenerative disorder characterized by high morbidity due to the limited regenerative capacity of dopaminergic neurons in the brain. Current drug treatments p
Parkinson Disease
ALC01 therapy
MRI Biomarkers in ALS N/A
COMPLETED · NCT02405182 · University of Alberta
145 enrolled · 2014-09 · → 2019-03
Amyotrophic lateral sclerosis (ALS) is a disabling and rapidly progressive neurodegenerative disorder. There is no treatment that significantly slows progression. Increasing age is an important risk f
Amyotrophic Lateral Sclerosis ALS Motor Neuron Diseases
Magnetic Resonance Imaging

📚 Cited Papers (49)

Paper:27568067
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Paper:30573821
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Diabetic neuropathy.
Nature reviews. Disease primers (2019) · PMID:31197153
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease.
Sleep (2018) · PMID:29425372
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Nucleotide signaling and cutaneous mechanisms of pain transduction.
Brain Res Rev (2009) · PMID:19171165
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Exposure to 1800 MHz radiofrequency radiation induces oxidative damage to mitochondrial DNA in primary cultured neurons.
Brain Res (2010) · PMID:19879861
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Views and experiences with regard to antibiotic use of hospitalized patients in five European countries: a qualitative descriptive study.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2019) · PMID:29777924
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Sleep drives metabolite clearance from the adult brain.
Science (2013) · PMID:24136970
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Challenges in the development of therapeutics for narcolepsy.
Progress in neurobiology (2017) · PMID:26721620
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
[
Nanoscale (2019) · PMID:30543234
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults.
Nature (2018) · PMID:29513649
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Reciprocal associations between depression, anxiety and work-related injury.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention (2020) · PMID:31685530
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link

📓 Linked Notebooks (1)

📓 Sleep disruption as cause and consequence of neurodegeneration — Analysis Notebook
CI-generated notebook stub for analysis sda-2026-04-01-gap-v2-18cf98ca. Sleep disruption as cause and consequence of neurodegeneration
→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

Wiki Pages

Yoga Therapy for NeurodegenerationtherapeuticYAP/TEAD Pathway Modulators for NeurodegenerationtherapeuticWnt Signaling Modulators for Neurodegenerationtherapeuticvitamin-d-therapy-neurodegenerationtherapeuticVitamin B Complex Therapy for NeurodegenerationtherapeuticVIP/VPAC Receptor Modulators for NeurodegenerationtherapeuticUrolithin A for NeurodegenerationtherapeuticUrolithin A for Neurodegenerationtherapeutictudca-udca-neurodegenerationtherapeuticTRPM8 Agonists for NeurodegenerationtherapeuticTriple Incretin Agonists (GLP-1/GIP/Glucagon) for therapeuticTREM2 Agonist Therapy for NeurodegenerationtherapeuticTranscranial Magnetic Stimulation Therapy for NeurtherapeuticTLR7/8/9 Antagonists for NeurodegenerationtherapeuticTLR4 Antagonists for Neurodegenerationtherapeutic

KG Entities (44)

ADORA2AADRA2AAMPKAQP4ATG5ATG7Astrocyte reactivity signalingBDNFBMAL1CACNA1GCLOCKCX3CR1Circadian rhythm / glymphatic clearanceHCRTHCRTR2HDACHypocretin/orexin wakefulness signalingLC3MAPTMTNR1A

Linked Experiments (3)

Brainstem Circuit Modulation for PSPclinical | tests | 0.40Sleep and Respiratory Network Interaction in ALS — Experiment Designclinical | tests | 0.40Neural Stem Cell Therapy for Alzheimer's Diseaseclinical | tests | 0.40

Related Hypotheses

SASP-Mediated Complement Cascade Amplification
Score: 0.703 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.692 | neurodegeneration
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector
Score: 0.675 | neurodegeneration
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.670 | neurodegeneration
Transcriptional Autophagy-Lysosome Coupling
Score: 0.665 | neurodegeneration

Estimated Development

Estimated Cost
$4M
Timeline
2.7 years

🧪 Falsifiable Predictions (21)

21 total 0 confirmed 0 falsified
Selective AQP4 upregulation without sleep improvement in transgenic models
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Selective AQP4 upregulation without sleep improvement in transgenic models
Glymphatic enhancement in awake states showing equal clearance benefits
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Glymphatic enhancement in awake states showing equal clearance benefits
Long-term AQP4 modulation studies showing no cognitive protection
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Long-term AQP4 modulation studies showing no cognitive protection
OR2 agonist treatment worsening sleep quality despite microglial changes
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: OR2 agonist treatment worsening sleep quality despite microglial changes
Orexin enhancement accelerating rather than slowing neurodegeneration
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Orexin enhancement accelerating rather than slowing neurodegeneration
Microglial depletion preventing orexin-mediated benefits
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Microglial depletion preventing orexin-mediated benefits
A2A antagonists providing superior cognitive protection than agonists
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: A2A antagonists providing superior cognitive protection than agonists
Metabolic enhancement without sleep improvement showing no neuroprotection
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Metabolic enhancement without sleep improvement showing no neuroprotection
Adenosine system manipulation having no effect on established neurodegeneration
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Adenosine system manipulation having no effect on established neurodegeneration
α2A agonists accelerating cognitive decline despite reducing tau pathology
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: α2A agonists accelerating cognitive decline despite reducing tau pathology
LC lesions preventing rather than promoting tau spread
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: LC lesions preventing rather than promoting tau spread
REM enhancement having no effect on established tau networks
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: REM enhancement having no effect on established tau networks
Circadian restoration without autophagy enhancement showing no benefits
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Circadian restoration without autophagy enhancement showing no benefits
Autophagy enhancement in circadian-disrupted models providing full protection
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Autophagy enhancement in circadian-disrupted models providing full protection
Clock gene manipulation worsening neurodegeneration despite improved autophagy
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Clock gene manipulation worsening neurodegeneration despite improved autophagy
Sleep spindle enhancement without memory improvement in MCI patients
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Sleep spindle enhancement without memory improvement in MCI patients
T-type channel modulation causing seizures or cardiac arrhythmias
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: T-type channel modulation causing seizures or cardiac arrhythmias
Spindle-independent memory consolidation pathways providing equal benefits
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Spindle-independent memory consolidation pathways providing equal benefits
Neurogenesis enhancement without cognitive benefits in human studies
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Neurogenesis enhancement without cognitive benefits in human studies
Hypocretin modulation disrupting rather than improving sleep architecture
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Hypocretin modulation disrupting rather than improving sleep architecture
BDNF manipulation causing adverse neurological effects
pending conf: 0.30
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: BDNF manipulation causing adverse neurological effects

Knowledge Subgraph (192 edges)

associated with (4)

ADORA2A neurodegeneration
ADRA2A neurodegeneration
CACNA1G neurodegeneration
HCRT neurodegeneration

causes (1)

MAPT tau_pathology

co associated with (21)

ADORA2A HCRT
ADORA2A HCRTR2
ADORA2A CACNA1G
ADORA2A CLOCK
ADORA2A MTNR1A
...and 16 more

co discussed (141)

BMAL1 HCRTR2
BMAL1 BDNF
BMAL1 AQP4
BMAL1 MTNR1A
BMAL1 CX3CR1
...and 136 more

co regulates (1)

CLOCK TFEB

controls (2)

adenosine_metabolism sleep_homeostasis
CX3CR1 microglial_activation

generates (1)

CACNA1G sleep_spindles

implicated in (7)

h-41bc2d38 neurodegeneration
h-de579caf neurodegeneration
h-b7898b79 neurodegeneration
h-4113b0e8 neurodegeneration
h-8597755b neurodegeneration
...and 2 more

mediates (1)

AQP4 glymphatic_clearance

modulates via microglia (1)

HCRTR2 CX3CR1

participates in (6)

ADORA2A Astrocyte reactivity signaling
MTNR1A Circadian rhythm / glymphatic clearance
ADRA2A Tau protein / microtubule-associated pathway
HCRTR2 Microglial activation / TREM2 signaling
CACNA1G Synaptic function / plasticity
...and 1 more

promoted: Adenosine-Astrocyte Metabolic Reset (1)

ADORA2A neurodegeneration

promotes (2)

glymphatic_clearance amyloid_beta_clearance
sleep_spindles memory_consolidation

regulates (1)

ADORA2A adenosine_metabolism

regulates expression (1)

MTNR1A AQP4

regulates propagation (1)

ADRA2A MAPT

Mechanism Pathway for HCRT

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    HCRTR2["HCRTR2"] -->|modulates via micr| CX3CR1["CX3CR1"]
    HCRT["HCRT"] -->|associated with| neurodegeneration["neurodegeneration"]
    HCRTR2_1["HCRTR2"] -->|participates in| Microglial_activation___T["Microglial activation / TREM2 signaling"]
    HCRT_2["HCRT"] -->|participates in| Hypocretin_orexin_wakeful["Hypocretin/orexin wakefulness signaling"]
    BMAL1["BMAL1"] -->|co discussed| HCRTR2_3["HCRTR2"]
    BMAL1_4["BMAL1"] -->|co discussed| HCRT_5["HCRT"]
    HCRTR2_6["HCRTR2"] -->|co discussed| CLOCK["CLOCK"]
    HCRTR2_7["HCRTR2"] -->|co discussed| BDNF["BDNF"]
    HCRTR2_8["HCRTR2"] -->|co discussed| AQP4["AQP4"]
    HCRTR2_9["HCRTR2"] -->|co discussed| MTNR1A["MTNR1A"]
    HCRTR2_10["HCRTR2"] -->|co discussed| CX3CR1_11["CX3CR1"]
    HCRTR2_12["HCRTR2"] -->|co discussed| HCRT_13["HCRT"]
    HCRTR2_14["HCRTR2"] -->|co discussed| CACNA1G["CACNA1G"]
    HCRTR2_15["HCRTR2"] -->|co discussed| ADORA2A["ADORA2A"]
    HCRTR2_16["HCRTR2"] -->|co discussed| ADRA2A["ADRA2A"]
    style HCRTR2 fill:#ce93d8,stroke:#333,color:#000
    style CX3CR1 fill:#ce93d8,stroke:#333,color:#000
    style HCRT fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style HCRTR2_1 fill:#ce93d8,stroke:#333,color:#000
    style Microglial_activation___T fill:#81c784,stroke:#333,color:#000
    style HCRT_2 fill:#ce93d8,stroke:#333,color:#000
    style Hypocretin_orexin_wakeful fill:#81c784,stroke:#333,color:#000
    style BMAL1 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_3 fill:#ce93d8,stroke:#333,color:#000
    style BMAL1_4 fill:#ce93d8,stroke:#333,color:#000
    style HCRT_5 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_6 fill:#ce93d8,stroke:#333,color:#000
    style CLOCK fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_7 fill:#ce93d8,stroke:#333,color:#000
    style BDNF fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_8 fill:#ce93d8,stroke:#333,color:#000
    style AQP4 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_9 fill:#ce93d8,stroke:#333,color:#000
    style MTNR1A fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_10 fill:#ce93d8,stroke:#333,color:#000
    style CX3CR1_11 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_12 fill:#ce93d8,stroke:#333,color:#000
    style HCRT_13 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_14 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_15 fill:#ce93d8,stroke:#333,color:#000
    style ADORA2A fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2_16 fill:#ce93d8,stroke:#333,color:#000
    style ADRA2A fill:#ce93d8,stroke:#333,color:#000

Predicted Protein Structure

🔮 HCRT — AlphaFold Prediction O43612 Click to expand 3D viewer

AI-predicted structure from AlphaFold | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | completed